CRBP · ISSUER CIK 1595097
Corbus Pharmaceuticals Holdings, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 5 Corbus Pharmaceuticals Holdings, Inc. insiders reported $25K of open-market purchases and $308K of sales on SEC Form 4. The largest buyer was Saxena Nishant C (Chief Business Officer), with $25K.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 3 of 3 sales were reported under a 10b5-1 plan.
$25KInsider buying
$308KInsider selling
−$283KNet open-market
Sep 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202616:59 | Sep 14, 2026 | CRBP | Director | S · Sell10b5-1 | $7.84 | −2,000 | 9,383 | -18% | −$16K | ||
| Aug 17, 202616:30 | Aug 16, 2026 | CRBP | Chief Medical Officer | A · Grant | — | +58,333 | 58,333 | New | — | ||
| Aug 12, 202616:30 | Aug 11, 2026 | CRBP | Chief Business Officer | P · Buy | $9.63 | +2,600 | 77,900 | +3% | +$25K | -20.8% | -56.2% |
| Aug 10, 202616:30 | Aug 7, 2026 | CRBP | Chief Executive Officer, Director | S · Sell10b5-1 | $10.08 | −17,000 | 157,316 | -10% | −$171K | ||
| Aug 10, 202616:30 | Aug 7, 2026 | CRBP | Chief Financial Officer | S · Sell10b5-1 | $10.08 | −12,000 | 84,694 | -12% | −$121K |